
24.80 Delayed Data As of Jan 27 | ![]() Today’s Change | 11.15 Today|||52-Week Range 29.68 | +19.23% Year-to-Date |
Bausch Health (BHC) Dry Eye Treatment Study Enrollment Complete Jan 20 / Zacks.com - Paid Partner Content |
Previous close | 26.45 |
Today’s open | 26.01 |
Day’s range | 24.58 - 26.13 |
Volume | 8,264,616 |
Average volume (3 months) | 3,861,292 |
Market cap | $9.5B |
Earnings growth (last year) | +56.99% |
Earnings growth (this year) | -14.68% |
Earnings growth (next 5 years) | +8.60% |
Revenue growth (last year) | +2.64% |
P/E ratio | NM |
Price/Sales | 1.23 |
Price/Book | 8.84 |
Today’s change | Today’s % change | |
---|---|---|
JAZZJazz Pharmaceuticals... | -2.14 | -1.29% |
RAREUltragenyx Pharmaceu... | -4.01 | -2.86% |
IONSIonis Pharmaceutical... | -3.31 | -5.29% |
MRTXMirati Therapeutics ... | -9.84 | -4.83% |
Next reporting date | February 24, 2021 |
EPS forecast (this quarter) | $1.09 |
Annual revenue (last year) | $8.6B |
Annual profit (last year) | -$1.8B |
Net profit margin | -20.79% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Laval, Quă©bec |